Abstract
Objective: There is reasonably strong data to suggest that lymphadenectomy may be safely omitted in women with apparent early-stage endometrioid endometrial cancer (EC) and low-risk uterine specimen features. However, among patients with uterine specimen features that suggest HIR-EC, such as lymphovascular space invasion (LVSI), FIGO grade 2 or 3 histology (G2/3), or outer half myometrial invasion (OI), there is no consensus on the utility of performing lymphadenectomy. Our aim was to review our experience and outcomes among a focused subset of women with HIR-EC who did and did not have lymphadenectomy.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call